Skip to main content
. 2019;20(9):2781–2787. doi: 10.31557/APJCP.2019.20.9.2781

Table 1.

Half Maximal Inhibitory Concentration (IC50) of Erlotinib Alone and in Combination with miRNAs in A549 Cells

Treatment IC50
24 h 48 h
Erlotinib 21.47 ± 1.18 14.26 ± 1.83
NC miRNA and erlotinib 20.35 ± 1.11# 13.17 ± 1.42#
miRNA-145 and erlotinib 11.36 ± 2.13* 7.63 ± 0.66*

IC50 values were calculated by sigmoidal dose-response (variable slope) model using GraphPad Prism software. Results expressed as the mean±SD (n=3). *p<0.05 versus erlotinib; #p>0.05 relative to the erlotinib.